BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Press Releases

  SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million

  July 17, 2024

   · 

  3 min read
• Press Releases

  Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call

  July 17, 2024

   · 

  1 min read
• Press Releases

  Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins

  July 17, 2024

   · 

  3 min read
• Press Releases

  CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

  July 17, 2024

   · 

  9 min read
• Press Releases

  Ancilia Biosciences Announces Closing of $4.2 Million Financing

  July 17, 2024

   · 

  4 min read
• Press Releases

  Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease at the Alzheimer’s Association International Conference, Philadelphia, July 31, 2024

  July 17, 2024

   · 

  7 min read
• Press Releases

  Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling

  July 17, 2024

   · 

  2 min read
• Press Releases

  [Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity

  July 17, 2024

   · 

  9 min read
• Press Releases

  First procedure in Netherlands with NaoTrac surgical navigation robot is performed at Erasmus MC Rotterdam

  July 17, 2024

   · 

  2 min read
• Press Releases

  4DMT Announces Positive Phase 2 PRISM Interim Results for Intravitreal 4D-150 in a Broad Wet AMD Population Affirming Favorable Safety Profile and Robust Clinical Activity

  July 17, 2024

   · 

  12 min read